Liang et al. found that rejuvenation of aged MSC via overexpressing Erb-B2 receptor tyrosine kinase 4 (ERBB4) could enhance angiogenesis via PI3K/AKT and MAPK/ERK pathways [81], which may improve the potential efficacy of MSCs in treating AKI. Here, ERBB4 is linked to acute kidney injury.